This site is intended for healthcare professionals

Round Up Email May 2024

In this month's Round Up areas highlighted include the synergistic action of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes in the reduction of cardiovascular risk, aspirin and breast cancer, and exercise and inflammatory bowel disease (IBD).

  • Question 1

    Finasteride – risk of psychiatric side effects and of sexual side effects – can the sexual dysfunction (including decreased libido and erectile dysfunction) associated with use of finasteride persist after the medication is stopped? Is depression or psychosis associated with use of finasteride?: Finasteride – risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)

    With respect to the use of finasteride, which statement is false?

  • Question 2

    Postponement of menstruation – in order for norethisterone 5mg three times a day to be effective for postponement of menstruation then how long before the predicted menses should this medication be commenced? Oral medroxyprogesterone is an alternative to norethisterone in management of postponement of menses – can this drug affect fertility?: Postponing menstruation

    With respect to the postponement of menstruation, which statement is false?

  • Question 3

    Use of oxygen in chronic respiratory failure due to COPD – this section in GPnotebook has been updated: Oxygen therapy in chronic respiratory failure due to COPD

    With respect to oxygen therapy in chronic respiratory failure in COPD, which statement is false?

  • Question 4

    Exercise and IBD – the relationship between exercise and IBD is summarised on GPnotebook.: Exercise and inflammatory bowel disease (IBD)

    With respect to exercise and inflammatory bowel disease (IBD), which statement is false?

  • Question 5

    Aspirin and breast cancer – is aspirin an evidence based adjunctive therapy in breast cancer?: Aspirin in breast cancer

    With respect to the use of aspirin in cancer, which statement is false?

  • Question 6

    Use of combination of SGLT2 inhibitor plus GLP1 agonist and cardiorenal benefits – the benefits associated with combination of these agents is summarised on GPnotebook: SGLT2 inibitors in comparison with (or in addition to) GLP1 agonists - cardiovascular and renal benefits

    With respect to combination therapy with SGLT2 inhibitors and GLP-1 agonists, which statement is false?